Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2009-11-06
2011-12-27
Anderson, Rebecca (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C548S537000
Reexamination Certificate
active
08084622
ABSTRACT:
An industrially advantageous process for the production of (3R,4S)-3-cyclopropylaminomethyl-4-fluoropyrrolidine or an enantiomer thereof that is useful as an intermediate for the production of novel antimicrobial agents 10-(3-cyclopropylaminomethyl-4-fluoropyrrolidinyl)pyridobenzoxazine carboxylic acid derivatives.Highly stereoselective asymmetric hydrogenation of 1-protected-4-alkoxycarbonyl-3-oxopyrrolidine, followed by ester hydrolysis, followed by amidation with cyclopropylamine gives crude crystals. The crude crystals are purified by recrystallization to give a novel compound (3R,4S)-1-protected-3-cyclopropylcarbamoyl-4-hydroxypyrrolidine or an enantiomer thereof at high optical purity. The use of these intermediates enables industrial production of high-quality products of (3R,4S)-3-cyclopropylaminomethyl-4-fluoropyrrolidine or an enantiomer thereof. The process is highly simple and can produce the desired products at high purity and stable yields.
REFERENCES:
patent: 7153851 (2006-12-01), Asahina et al.
patent: 2005/0182052 (2005-08-01), Asahina et al.
patent: 2006/0281779 (2006-12-01), Asahina et al.
patent: 2005-239617 (2005-09-01), None
patent: 03/078439 (2003-09-01), None
patent: 2005/026147 (2005-03-01), None
International Search Report issued May 29, 2007 in International (PCT) Application No. PCT/JP2007/054501 corresponding to the parent application of the present divisional application.
Morissette et al., “High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids”, Advanced Drug Delivery Reviews, 56, 275-300, 2004.
Sudha R. Vippagunta, “Crystalline Solids”, Advanced Drug Delivery Reviews, 48, 3-26, 2001.
Araya Ichirou
Gotoh Takayuki
Anderson Rebecca
Kyorin Pharmaceutical Co. Ltd.
Otton Alicia L
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Process for producing 3,4-disubstituted pyrrolidine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for producing 3,4-disubstituted pyrrolidine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for producing 3,4-disubstituted pyrrolidine... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4304136